Quest Diagnostics CEO Sells Shares Worth $2.4 Million
On September 1, 2026, J.E. Davis, the CEO of Quest Diagnostics (NYSE:DGX), sold 10,000 shares at a price of $242.72 per share under a Rule 10b5-1 trading plan. This transaction is part of an established strategy for insider trades and does not necessarily reflect any negative sentiment toward the company's performance or future prospects. Following this sale, Davis still holds 122,423 shares directly in Quest Diagnostics, with a post-transaction value estimated at $28.9 million as of September 1 market close ($236.22 per share). The stock has delivered strong returns over the past year, posting a total return of 32% through the transaction date. The company remains in solid financial health with TTM revenue reaching $11.6 billion and net income at $1.1 billion as of September 2026. Investors are advised not to be overly concerned by this insider sale, which is a routine liquidity move rather than an indicator of strategic or operational issues.
Tickers: $DGX
Topics: CEO Rule 10b5-1 SEC filing stock sale